These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 33922473)
1. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling. Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473 [TBL] [Abstract][Full Text] [Related]
2. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240 [TBL] [Abstract][Full Text] [Related]
3. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study. Chung H; Fierro A; Pessoa-Mahana CD PLoS One; 2019; 14(7):e0220025. PubMed ID: 31335889 [TBL] [Abstract][Full Text] [Related]
4. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe. Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127 [TBL] [Abstract][Full Text] [Related]
5. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874 [TBL] [Abstract][Full Text] [Related]
6. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target. Janero DR; Thakur GA Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124 [TBL] [Abstract][Full Text] [Related]
7. The future of type 1 cannabinoid receptor allosteric ligands. Alaverdashvili M; Laprairie RB Drug Metab Rev; 2018 Feb; 50(1):14-25. PubMed ID: 29355038 [TBL] [Abstract][Full Text] [Related]
9. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons. Straiker A; Dvorakova M; Zimmowitch A; Mackie K Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991 [TBL] [Abstract][Full Text] [Related]
11. Allosteric Modulators of the CB Morales P; Goya P; Jagerovic N; Hernandez-Folgado L Cannabis Cannabinoid Res; 2016; 1(1):22-30. PubMed ID: 28861476 [TBL] [Abstract][Full Text] [Related]
12. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256 [TBL] [Abstract][Full Text] [Related]
13. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor. Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547 [TBL] [Abstract][Full Text] [Related]
14. Adenosine A Aso E; Fernández-Dueñas V; López-Cano M; Taura J; Watanabe M; Ferrer I; Luján R; Ciruela F Mol Neurobiol; 2019 Aug; 56(8):5382-5391. PubMed ID: 30610611 [TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications. Kulkarni AR; Garai S; Janero DR; Thakur GA Methods Enzymol; 2017; 593():281-315. PubMed ID: 28750808 [TBL] [Abstract][Full Text] [Related]
17. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Laprairie RB; Bagher AM; Kelly ME; Denovan-Wright EM Br J Pharmacol; 2015 Oct; 172(20):4790-805. PubMed ID: 26218440 [TBL] [Abstract][Full Text] [Related]
18. Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities. Hryhorowicz S; Kaczmarek-Ryś M; Andrzejewska A; Staszak K; Hryhorowicz M; Korcz A; Słomski R Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771126 [TBL] [Abstract][Full Text] [Related]
19. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist. Pandey P; Roy KK; Doerksen RJ J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534 [TBL] [Abstract][Full Text] [Related]
20. Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor. Saleh N; Hucke O; Kramer G; Schmidt E; Montel F; Lipinski R; Ferger B; Clark T; Hildebrand PW; Tautermann CS Angew Chem Int Ed Engl; 2018 Mar; 57(10):2580-2585. PubMed ID: 29314474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]